Healthcare Staffing Valuation Multiples: EBITDA, Gross Margin, and Buyer Demand

Why healthcare staffing multiples are easy to misread

Healthcare staffing companies can show large revenue numbers because staffing is a high-throughput operating model. A company may bill tens of millions of dollars while only a portion of that revenue converts into gross profit and a smaller portion converts into EBITDA. That is why sophisticated buyers rarely value these companies on revenue alone. They start by asking what earnings are real, recurring, financeable, and defensible after a change of control.

The more difficult issue is that even EBITDA can mislead if the underlying operating data is weak. A company may report strong EBITDA because of temporary crisis-rate pricing, one unusually large hospital account, a favorable MSP relationship, underinvestment in compliance infrastructure, or delayed expense recognition. Another company may show slightly lower EBITDA but stronger direct contracts, better redeployment, more stable gross margin, lower DSO, and a management team that can operate without the founder. The second business may receive the stronger multiple.

This is why the question “what multiple do healthcare staffing companies sell for?” should be treated as a starting point, not a finish line. The better question is: what evidence would make a buyer believe the company’s earnings deserve the upper end of the range? That is the lens used throughout this article.

Executive summary

Healthcare staffing valuation multiples are most often anchored to normalized EBITDA. Buyers usually establish a starting corridor by looking at similar staffing and healthcare workforce transactions, then adjust the multiple up or down based on scale, segment mix, growth durability, gross margin quality, fulfillment performance, contract durability, concentration, compliance discipline, and working-capital behavior.

The most valuable healthcare staffing companies do not simply have growth. They have growth that buyers can underwrite. That means stable bill/pay spread, clean gross margin by segment and customer, reliable fill rate, shorter time-to-fill, recurring assignment demand, clinician redeployment, organized credentialing files, strong billing discipline, and financial reporting that survives quality-of-earnings diligence.

Owners should also separate enterprise value from cash at close. The multiple produces enterprise value, but proceeds depend on debt, cash, debt-like items, working capital, escrow, rollover equity, earnouts, seller notes, and purchase-price adjustments. A premium multiple does not help much if the earnings base is cut during QoE or if working capital absorbs a larger-than-expected portion of value.

Key takeaways for healthcare staffing owners

• Healthcare staffing companies are usually valued on buyer-accepted normalized EBITDA, not revenue alone.
• Published multiple ranges are only useful after the buyer understands service-line mix, gross margin quality, customer concentration, and cash conversion.
• Travel nurse staffing, allied health staffing, per diem nursing, locum tenens, and multi-service workforce platforms can command different multiples because their risk profiles differ.
• Gross margin quality matters more than a single gross margin percentage. Buyers want evidence that spread is durable across customer, specialty, branch, and channel mix.
• Fill rate, time-to-fill, assignment length, extension rates, and clinician redeployment affect whether EBITDA is scalable or fragile.
• Working-capital mechanics can materially change seller proceeds even if the headline EBITDA multiple appears attractive.
• Preparation improves outcomes when it reduces the gap between the seller’s multiple narrative and what buyers can verify during diligence.

The buyer valuation map from EBITDA to proceeds

Buyers usually build a healthcare staffing valuation in a sequence. Normalized EBITDA establishes the earnings base. The starting multiple reflects market evidence and buyer type. The final multiple reflects company-specific underwriting. Then enterprise value is bridged to equity value and proceeds through debt, cash, working capital, escrow, rollover, and other deal terms.

This sequencing is important because sellers often anchor on the multiple while buyers are still testing the underlying inputs. The logic is similar to Auxo’s broader guide to how buyers build a valuation model, but healthcare staffing adds additional sensitivity around labor fulfillment, credentialing, billing, payroll timing, and account durability.

A multiple is only one input in healthcare staffing valuation

A healthcare staffing multiple becomes useful only after the buyer agrees on the earnings base. A seller may describe the company as a $40 million revenue healthcare staffing platform, but a buyer will ask how much of that revenue converts into gross profit, how much gross profit converts into normalized EBITDA, and how much of that EBITDA remains transferable after wage pressure, recruiter productivity, compliance cost, customer concentration, and working-capital needs are reviewed.

This is why the multiple alone can overstate value. A higher multiple on an aggressive EBITDA base may produce a weaker result than a lower multiple on clean, buyer-accepted earnings. The better question is whether the buyer trusts the EBITDA and whether the resulting enterprise value converts into seller proceeds. Auxo’s guide to enterprise value to seller proceeds explains why headline valuation and closing economics can diverge.

EBITDA multiples, revenue multiples, and gross-profit references are not interchangeable

Healthcare staffing companies may generate large revenue because clinician payroll passes through the model. Revenue scale matters, but revenue alone does not tell a buyer whether the business has strong bill/pay spread, recruiter leverage, compliance discipline, or cash conversion. That is why institutional buyers usually anchor valuation to normalized EBITDA rather than revenue.

Revenue and gross-profit references can still be useful. They may help buyers compare early-stage businesses, high-growth segments, or companies whose EBITDA is temporarily distorted by branch expansion, recruiter investment, or market normalization. But those references are usually secondary checks. A revenue multiple without gross margin quality can mislead. A gross-profit reference without overhead discipline can also mislead. EBITDA underwriting connects revenue quality, margin conversion, and operating infrastructure in one view.

For a broader explanation of how buyers compare valuation bases, see Auxo’s article on EBITDA multiples versus revenue multiples. In healthcare staffing, sophisticated buyers may reference revenue or gross profit, but they usually return to EBITDA once the company’s staffing economics are organized.

Why the “average healthcare staffing multiple” is usually the wrong anchor

Owners often search for an average healthcare staffing multiple because it feels like a shortcut. The problem is that averages blend travel nurse staffing, allied health staffing, per diem nursing, locum tenens, direct-contract models, VMS/MSP-heavy models, regional tuck-ins, and multi-service platforms. Those businesses can have very different margin quality, contract durability, compliance requirements, and buyer universes.

The better question is not “what is the average multiple?” The better question is what multiple a specific buyer would apply to a specific earnings stream after normalizing EBITDA, testing concentration, reviewing gross margin by segment, and assessing whether the business fits that buyer’s strategy. A quick estimate from Auxo’s business valuation calculator can help frame the basic math, but a calculator cannot see VMS dependence, recruiter concentration, credentialing gaps, DSO drift, or whether a buyer will require rollover, escrow, or an earnout.

Auxo’s guide to what goes into a business valuation explains the broader inputs, while how buyers build a valuation model explains why sophisticated buyers still re-underwrite any initial range before turning it into a transaction offer.

Definitions that matter in healthcare staffing multiple discussions

Normalized EBITDA is the buyer-accepted earnings base after adjusting reported profit for non-recurring, owner-specific, discretionary, or non-market items. In staffing, this may include excess owner compensation, unusual legal expense, one-time recruiting campaigns, discontinued branch losses, or costs that were under-accrued historically.

Bill/pay spread is the difference between what the staffing company bills the customer and what it pays the clinician, before considering other direct costs, payroll burden, and overhead. Buyers care about whether that spread is stable and repeatable.

Gross margin quality is broader than the reported percentage. Buyers evaluate margin by specialty, customer, branch, channel, assignment type, and period to understand whether the economic profile is durable.

Fill rate and time-to-fill measure how reliably and quickly the company converts open orders into staffed assignments. Weak performance can reduce confidence in growth and margin stability.

DSO, or days sales outstanding, measures collection speed. In healthcare staffing, DSO is especially important because payroll often runs ahead of collections.

Indicative healthcare staffing EBITDA multiple ranges by segment

The table below is an indicative framework for founder-led, profitable healthcare staffing companies that are large enough to attract institutional or strategic buyer interest. It is not a promise, appraisal, fairness opinion, or transaction quote. A company can price above or below these ranges based on scale, growth, concentration, compliance, management depth, buyer fit, financing conditions, and the quality of the process.

These ranges are most useful when paired with the driver sections below. A locum tenens company with weak enrollment controls and concentration can trade below a well-run allied health platform. A travel nurse company with clean post-pandemic normalization, diversified direct accounts, and stronger cash conversion can outperform a generic range. Buyers are not pricing the label; they are pricing the risk inside the cash flow.

What moves a healthcare staffing company toward the low end or high end of the range

Healthcare staffing multiples expand when buyers see evidence that EBITDA is clean, repeatable, compliant, and financeable. They compress when the buyer sees uncertainty in gross margin, fulfillment reliability, client concentration, compliance controls, or cash conversion. The same revenue base can therefore land in very different valuation bands.

Multiple expansion usually depends on evidence. A seller cannot simply describe the company as a platform; buyers need to see branch-level margin analytics, customer-level revenue and gross profit, recruiter productivity, fill rate, assignment duration, redeployment, collections quality, and compliance controls. When the evidence is weak, the company may still trade, but not at the top of the range.

Gross margin quality is the first major pricing filter

Healthcare staffing buyers rarely stop at a single gross margin percentage. They ask whether margin is supported by durable customer pricing, specialty scarcity, direct-account access, disciplined pay-rate management, and efficient fulfillment. A company that produced strong recent EBITDA because of temporary rate dislocation may receive a lower multiple than a company with more modest but repeatable spread performance.

Margin is also tested by mix. Travel nurse staffing, allied health, locum tenens, per diem nursing, and permanent placement can have different gross margin profiles, different cash conversion cycles, and different overhead requirements. A blended margin number may hide the fact that the highest-margin revenue is also the least predictable or that a large customer is absorbing more recruiter capacity than management realized.

Buyers pressure-test margin quality through quarterly spread trends, gross profit by customer, gross profit by specialty, direct versus VMS/MSP mix, overtime and stipend exposure, cancellation patterns, falloff rates, recruiter productivity, and whether premium pay is required to sustain fill performance. If the evidence shows durable spread and disciplined fulfillment, the multiple can expand. If the evidence shows temporary demand, weak pricing control, or rising labor acquisition cost, the multiple compresses.

Utilization, fill rate, and assignment economics can move the range quickly

Staffing businesses create value by converting demand into staffed assignments at acceptable economics. In healthcare staffing, buyers focus on fill rate, time-to-fill, assignment length, completion rates, extension rates, and clinician redeployment because those metrics reveal whether EBITDA is the product of a repeatable system or a constant scramble.

A company that consistently fills orders quickly, extends assignments, and redeploys clinicians efficiently usually receives more buyer confidence. That pattern suggests lower sourcing friction, better customer retention, stronger recruiter leverage, and less margin leakage. A company that relies on constant fresh sourcing, heavy premium pay, or long time-to-fill may still generate revenue, but buyers may view the earnings as less scalable.

These operating metrics also affect the forecast. Buyers do not simply assume the trailing twelve months will repeat. They ask whether recruiter productivity, credentialing throughput, clinician supply, account demand, and compliance infrastructure can support the forecast under normalized market conditions. That is why healthcare staffing multiples often move during diligence: the buyer’s view of future EBITDA changes as the operating data becomes clearer.

Contract durability separates platforms from transactional volume stories

Revenue quality depends heavily on how customer demand is sourced, retained, and monetized. Buyers generally prefer diversified relationships with hospital systems, post-acute providers, outpatient clinics, physician groups, and other healthcare organizations where the staffing company has measurable service performance and repeat demand. They are more cautious when revenue is driven by a narrow set of contracts, a single MSP relationship, or episodic surge demand.

VMS and MSP channels require careful positioning. They can provide volume and access to important accounts, but they can also compress margin, reduce differentiation, limit pricing control, and create dependence on order flow outside the company’s control. The same VMS relationship can be a positive or a negative depending on margin, concentration, renewal history, order quality, and the company’s ability to source through other channels.

Where concentration is elevated, buyers may still pursue the company, but they often protect themselves through a lower multiple, customer-specific diligence conditions, earnout exposure, escrow, or more conservative debt support. Owners preparing for market should understand these issues before outreach, not after an indication of interest. That preparation connects directly to Auxo’s guide on How to Sell a Healthcare Staffing Company and the execution roadmap in the Sell-Side M&A Process.

Why travel nurse, allied health, per diem, and locum tenens multiples differ

Healthcare staffing is not one homogeneous market. Buyers view each segment through its own risk and opportunity profile. Travel nurse staffing often attracts attention because of scale and demand visibility, but buyers may be cautious if recent performance reflects crisis-era pricing, compressed spreads, or heavy reliance on a small group of facilities or MSP relationships. The valuation question is whether the post-normalization business still has durable earnings.

Allied health staffing may attract buyer interest because the specialty base can be more diversified across therapy, imaging, lab, respiratory, and other clinical roles. The multiple depends on specialty scarcity, customer diversity, margin stability, and whether the platform has credible recruiting systems rather than one-off relationships. Per diem nursing can be attractive where local density is strong, but it may be underwritten more conservatively if shift demand is highly transactional or if fill reliability depends on a few coordinators.

Locum tenens can support stronger valuation when provider supply, specialty depth, and repeat facility demand are well documented. It can also be more complex because credentialing, provider enrollment, placement cycle length, and cash timing can distort simple comparisons. Owners with a meaningful physician-coverage or advanced-practice component should review Auxo’s dedicated resource on Locum Tenens Staffing M&A before assuming a generic healthcare staffing multiple applies.

Working-capital discipline affects both valuation confidence and cash at close

Healthcare staffing companies often pay clinicians before customers pay invoices. That creates a working-capital profile that buyers and lenders examine closely. DSO, unbilled receivables, billing delays, disputed invoices, payroll timing, accrued compensation, payroll taxes, and funding lines can all affect the bridge from enterprise value to equity value.

Working capital can affect value in two ways. First, weak collections, inconsistent billing, or unexplained AR aging can reduce confidence in reported earnings quality. Second, the purchase agreement may require the seller to deliver a normalized level of net working capital at close. If the company delivers less than the agreed target, the purchase price is usually adjusted downward. That can reduce cash at close even if the headline multiple remains unchanged.

Owners should review Working Capital: Avoid Price Chips and Working Capital Peg: EV to Equity Bridge because these mechanics are especially relevant in staffing deals. The best time to tighten billing, AR review, and payroll accrual discipline is before the market process begins.

QoE is where the multiple gets defended or repriced

Quality of earnings is often the moment when a healthcare staffing multiple becomes real. Before QoE, buyers may discuss a range based on management materials and high-level financials. During QoE, they test whether normalized EBITDA, margin trends, revenue recognition, AR quality, direct labor costs, and add-backs are supportable.

Buyers commonly flag revenue concentration by customer, facility, specialty, and recruiter; gross margin variance by branch, customer, assignment type, and channel; credentialing or compliance exceptions that could affect billability; provider enrollment delays; unusual timing in commissions, bonuses, stipends, or payroll burden; AR aging concentrations; write-offs and disputed invoices; one-time demand spikes presented as recurring performance; and adjustments that are weakly documented or operationally necessary.

A clean QoE can strengthen the seller’s ability to defend both EBITDA and the selected multiple. A messy QoE often does the opposite: it reduces adjusted EBITDA, lowers buyer confidence, increases structure, and creates late-stage leverage for retrade. Auxo’s guide to QoE issues buyers flag is a useful companion for owners preparing a data room or pre-market valuation package.

Trailing EBITDA, run-rate EBITDA, and forward EBITDA can create different multiple conversations

Healthcare staffing owners sometimes argue that buyers should value the company on current run-rate or forward EBITDA rather than trailing twelve-month performance. That can be reasonable when recent improvement is supported by signed contracts, proven placements, stable bill/pay spread, documented recruiter productivity, and collections that have already begun converting into cash. It is less persuasive when the run-rate case depends on unproven branch expansion, temporary rate spikes, one large account, or a labor market condition buyers believe is normalizing.

Buyers usually compare TTM EBITDA, run-rate EBITDA, and the forward case before deciding which earnings base deserves a multiple. If a staffing company can show that new contracts are active, clinicians are deployed, gross margin is stable, and DSO is not deteriorating, a buyer may give partial forward credit. If the forecast is speculative, the buyer may use trailing EBITDA, apply a lower multiple, or push value into contingent consideration.

The same multiple can produce different seller proceeds

A healthcare staffing seller should distinguish between quoted multiple, underwritten multiple, and realized multiple. A buyer may quote an attractive EBITDA multiple, but the economics can change if QoE reduces EBITDA, the buyer identifies debt-like items, the working-capital peg is higher than expected, or meaningful value is pushed into rollover equity, escrow, seller note, or earnout.

This matters because deal structure can make two offers with similar headline multiples feel very different. One buyer may offer a slightly lower enterprise value with more cash at close and cleaner closing mechanics. Another may offer a higher headline multiple but require more rollover equity, more contingent value through earnouts, or a tighter working capital peg. Purchase-price mechanics can also change the economics through purchase price adjustments after closing.

A disciplined process compares total economics, not just enterprise value. Sellers should ask how each bid converts to cash at close, how much value remains at risk, what assumptions must be met after closing, and how much control the seller retains over those outcomes.

Where valuation calculators help, and where buyer underwriting takes over

A valuation calculator can help a staffing owner see the basic math of EBITDA, multiple, enterprise value, debt, working capital, and estimated equity value. Auxo’s business valuation calculator can be useful as an initial sensitivity tool, particularly for founders who want to understand how a half-turn of multiple movement or a change in adjusted EBITDA affects headline value.

The limitation is that a calculator cannot know whether a travel nurse staffing company’s margin is normalized, whether allied health demand is concentrated in one customer, whether locum tenens provider enrollment is slowing placements, whether DSO is masking a cash-conversion issue, or whether a buyer will require rollover, escrow, seller note, or earnout protection. Those are underwriting questions.

The better use is to treat calculators as a first-pass orientation tool, then move into the inputs a buyer will verify. Resources on what goes into a business valuation calculator and Healthcare Staffing Business Valuation are useful next steps because they explain why the same formula can produce different real-world outcomes once QoE, working capital, buyer type, and segment risk are introduced.

Worked example: similar revenue, very different value

Consider two founder-led healthcare staffing companies, each with approximately $40 million of revenue. On the surface, they may appear similar. In buyer underwriting, they separate quickly because normalized EBITDA, multiple selection, working-capital adjustment, and structure do not move together evenly.

The lesson is not simply that Company A received a higher multiple. Cleaner transferability improved buyer-accepted EBITDA, supported a stronger multiple, reduced working-capital friction, and produced a cleaner proceeds profile. Company B did not lose value because healthcare staffing demand disappeared. It lost value because the buyer saw weaker earnings quality, weaker contract durability, weaker cash conversion, and more risk allocation pressure.

This is why sellers should model valuation as a range with sensitivity, not a single number. A modest EBITDA change, half-turn multiple movement, or working-capital adjustment can change cash at close materially. Owners should understand how enterprise value turns into seller proceeds, how purchase-price adjustments work, and why cash-free debt-free conventions matter in staffing transactions.

Where diligence most often changes the multiple

Diligence changes healthcare staffing multiples when the buyer’s original assumptions prove too optimistic. Common pressure points include customer concentration, AR aging, unbilled revenue, gross margin by customer, unsupported add-backs, credentialing exceptions, contractor classification issues, VMS/MSP dependence, recruiter concentration, and weak documentation around assignment starts, extensions, and cancellations.

Sometimes the buyer reduces the multiple. Sometimes the buyer keeps the headline multiple but changes the economics through structure. A purchase agreement that adds escrow, holdback, earnout, rollover, indemnity protection, or a tougher working-capital adjustment can reduce the realized multiple even if the stated enterprise value appears unchanged. Auxo’s guide to why deals lose value during due diligence explains the broader pattern behind these re-trades, and the distinction between quality of earnings and normalized EBITDA is often where the multiple reset begins.

Common mistakes when using healthcare staffing multiple ranges

The first mistake is applying a premium multiple to unnormalized EBITDA. If buyers reduce the earnings base during diligence, the same headline multiple produces a lower enterprise value. The second mistake is comparing revenue multiples without considering gross margin, recruiter productivity, compliance cost, concentration, and working capital.

The third mistake is assuming healthcare staffing demand automatically creates a premium. Buyers may like the sector, but they still discount weak reporting, fragile contracts, inconsistent fill rates, or founder-dependent relationships. The fourth mistake is ignoring structure. A higher multiple with heavy contingent consideration can be less attractive than a lower multiple with cleaner cash at close. Owners comparing offers should evaluate price, certainty, structure, employment commitments, rollover, earnouts, indemnities, and post-close control. Auxo’s guide to how founders should compare two M&A offers provides a useful framework for that analysis.

Seller takeaway

What buyers actually focus on in healthcare staffing diligence

Buyers rarely spend most of their time debating abstract multiple ranges. Once a process becomes serious, diligence narrows around a set of questions tied directly to cash flow and risk allocation. Can the company continue producing placements without margin erosion? Are credentialing, licensure, and compliance processes robust enough to scale? Is customer demand likely to persist after a change of control? Will the buyer inherit a cash conversion problem or an integration burden that was not obvious from the teaser and CIM?

They also compare the story to the data room. If management describes the business as a differentiated clinical workforce platform but the data shows heavy dependence on one MSP, weak redeployment, slow collections, or inconsistent credentialing, the multiple will usually move against the seller. If the narrative is supported by detailed operating data, the seller has a better chance of defending the selected range.

Buyer type shapes the emphasis. Strategic buyers may focus harder on integration fit, geography, account overlap, specialty mix, and cross-sell. Private equity buyers may lean more heavily into downside protection, leverage support, scalable management infrastructure, and add-on acquisition logic. Owners comparing likely bidders should read Healthcare Staffing Buyers alongside How Private Equity Actually Prices Deals in Practice and Why Strategic Buyers Pay More.

Why process discipline and positioning change valuation outcomes

In healthcare staffing transactions, value erosion often happens through a series of preventable concessions: weak normalization support, inconsistent KPI reporting, underdeveloped explanations for MSP exposure, poor AR support, a poorly defended working-capital peg, or a buyer list that misses the acquirers most likely to value the company’s niche. That is where advisory discipline matters.

An effective advisor does not manufacture value out of thin air. The role is to frame the business around the factors buyers truly underwrite, prepare evidence that supports normalized EBITDA, surface diligence-sensitive issues early, create competitive tension among relevant sponsor and strategic buyers, and negotiate beyond headline price. This includes structure, rollover, earnout terms, escrow, net debt treatment, purchase-price adjustments, and working-capital definitions.

For owners still calibrating timing, a pre-market view through Valuation Services or a broader market screen through the Market Value Study can be useful before a full sale process begins. Owners closer to execution should review Sell-Side M&A Advisory and the Sell-Side M&A Timeline to understand how preparation, outreach, diligence, and negotiation usually sequence.

Frequently asked questions

Related Auxo resources for valuation, buyer behavior, and deal preparation

Healthcare staffing valuation multiples are most useful when owners connect the range to buyer behavior, diligence mechanics, proceeds, and process design. The resources below are selected as next-step planning tools and avoid repeating every healthcare staffing link already used earlier in this article.

Advisory and valuation planning

• Mergers & Acquisitions Advisory Services — Auxo’s broader M&A advisory hub for founder-led and middle-market owners evaluating a sale, recapitalization, acquisition, or strategic alternative.
• Sell-Side M&A Advisory — How Auxo helps owners prepare, position, market, negotiate, and close a sale process.
• Capital Advisory Services — Relevant when owners are weighing a sale against recapitalization, minority investment, growth capital, acquisition financing, or other capital-structure alternatives.

Valuation and proceeds mechanics

• Enterprise Value vs. Equity Value — Explains why the business value buyers quote is not always the equity value sellers use to estimate proceeds.
• Enterprise Value vs. Purchase Price — Shows how headline enterprise value and final purchase-price mechanics can diverge.
• EBITDA Multiples vs. Revenue Multiples — Useful for understanding why buyers may reference revenue but still anchor value to normalized EBITDA.
• Normalized EBITDA vs. Adjusted EBITDA — Explains why buyer-accepted earnings may differ from management’s adjusted presentation.

Offer comparison and advisor selection

• How Founders Should Compare Two M&A Offers — A practical guide to comparing price, structure, certainty, and execution risk.
• Which M&A Advisors Provide the Most Buyer Exposure? — Helps owners understand why buyer access and process design affect price discovery.
• Sell-Side vs. Buy-Side M&A Advisors — Clarifies the difference between advisors representing sellers and advisors representing acquirers.
• M&A Advisor Leverage Diagnostic — A diagnostic resource for evaluating how advisor leverage, preparation, and process design may affect a transaction.

Used together, these resources help owners move from a market multiple estimate to the more important transaction question: how to protect and defend valuation when buyers begin testing earnings, margin quality, transferability, working capital, structure, and closing certainty.

Media & press inquiries

Auxo Capital Advisors welcomes relevant media and industry inquiries related to healthcare staffing M&A, valuation, buyer underwriting, provider-services consolidation, business services transactions, and middle-market deal trends.

For speaking, commentary, or press requests, email info@auxocapitaladvisors.com. Please include your outlet, deadline, topic, and any specific framing or data needs so the inquiry can be routed efficiently.

Disclosure

This article is provided for general informational purposes only and reflects a transaction advisory perspective on how buyers may evaluate healthcare staffing companies in sale, recapitalization, or strategic alternatives processes. It is not legal, tax, accounting, investment, valuation, regulatory, healthcare, or other professional advice, and it should not be relied on as a substitute for transaction-specific guidance.

Any examples, ranges, scenarios, formulas, or illustrative valuation bridges included above are simplified for explanatory purposes. Actual transaction outcomes depend on buyer-specific underwriting, diligence findings, negotiations, financing conditions, legal and tax structuring, working-capital definitions, net debt treatment, market conditions, contract durability, compliance matters, employment terms, and numerous company-specific facts. No valuation outcome, buyer interest level, multiple, or deal structure is implied or guaranteed by this discussion.

About the author

George Barsom is Founder & Managing Director of Auxo Capital Advisors. He advises founder-led and middle-market businesses on valuation, sell-side preparation, transaction positioning, and M&A execution.

His work focuses on translating operating performance into buyer-relevant underwriting narratives so owners can approach a sale, recapitalization, or capital process with clearer expectations around value, structure, and diligence risk. Auxo’s core practice areas include Mergers & Acquisitions Advisory Services, Capital Advisory Services, and Valuation Services.